Download PDF
Allgemeine Homöopathische Zeitung 2018; 263(02): 4-14
DOI: 10.1055/s-0043-125034
Spektrum
© Georg Thieme Verlag KG Stuttgart · New York

Eine für Alle – Alle für Eine(n)?

Über öffentliche Impfempfehlungen, den medizinischen Standard und die Herdenimmunität
Steffen Rabe
Further Information

Publication History

Publication Date:
16 April 2018 (online)

    Permissions and Reprints

Zusammenfassung

Den Impfempfehlungen der Ständigen Impfkommission (STIKO) kommt in der öffentlichen Diskussion in Deutschland zunehmend die Qualität eines Pflichtkatalogs zu, dessen verpflichtender Charakter vor allem mit dem Argument der durch flächendeckende Impfungen angenommenen Herdenimmunität begründet wird.

In dieser Arbeit wird nachgewiesen, dass es bei Impfempfehlungen keinen medizinischen Standard oder Konsens gibt und dass für die meisten empfohlenen Impfungen keine relevante Herdenimmunität angenommen werden kann.

Summary

The recommendations for immunization in Germany by the STIKO are increasingly interpreted as a mandatory catalogue all the more considering the supposedly implicit herd immunity induced by vaccination.

In this paper it is demonstrated that concerning immunization there is no medical standard or consensus and that for the majority of the recommended vaccinations no relevant herd immunity can be assumed.

Schlüsselwörter

Impfempfehlungen - Herdenimmunität

Keywords

Recommendations for immunization - herd immunity

Bibliografie

DOI https://doi.org/10.1055/s-0043-125034

AHZ 2018; 263: 4–14

© Georg Thieme Verlag KG Stuttgart. New York

ISSN 1438-2563

 

  • Literatur

  • 1 ABIM Foundation. Choosing wisely: Promoting conversations between providers and patients. Choosing wisely. Im Internet: www.choosingwisely.org; Stand: 06.01.2018
  • 2 Althouse BM. Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Medicine 2015 13. Im Internet: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-015-0382-8; Stand: 06.01.2018
    PubMedGoogle Scholar
  • 3 Anderson RM. May RM. Vaccination against rubella and measles: Quantitative investigations of different policies. J Hyg Camb 1983; 90: 259-325
    PubMedGoogle Scholar
  • 4 Ärztliches Zentrum für Qualität in der Medizin. Surrogatendpunkt — ÄZQ. Leitlinien.de 2016 Im Internet: www.leitlinien.de/glossar/surrogatendpunkt; Stand: 06.01.2018
    PubMed
  • 5 Barbour ML. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerging infectious diseases 1996; 2: 176
    PubMedGoogle Scholar
  • 6 Baxter R. Bartlett J. Fireman B. et al. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics 2017; 139: e20164091
    PubMedGoogle Scholar
  • 7 2 BGH. AZ VI ZR 48_99 – Urteil vom 15. 02.2000. Im Internet: http://juris.bundesgerichtshof.de/cgi-bin/rechtsprechung/document.py?Gericht=bgh&Art=en&nr=23581&pos=0&anz=1; Stand: 06.01.2018
  • 8 Castagnini LA. Healy CM. Rench MA. et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clinical Infectious Diseases 2012; 54: 78-84
    PubMedGoogle Scholar
  • 9 CDU. Sonstige Beschlüsse – 28. Parteitag der CDU Deutschlands 2015. Im Internet: www.cdu.de/system/tdf/media/dokumente/sonstige-beschluesse.pdf?file=1; Stand: 06.01.2018
  • 10 Centers for Disease Control and Prevention. Update mumps outbreak – New York and New Jersey, June 2009–January 2010. MMWR Morbidity and Mortality Weekly Report 2010; 59. 125-129
  • 11 Centers for Disease Control and Prevention. Mumps outbreak at a university and recommendation for a third dose of measles-mumps-rubella vaccine – Illinois, 2015–2016. MMWR Morbidity and Mortality Weekly Report 2016; 65: 731-734
    PubMedGoogle Scholar
  • 12 Centers for Disease Control and Prevention. Pertussis | Whooping Cough | Frequently Asked Questions | CDC. CDC 2017 Im Internet: www.cdc.gov/pertussis/about/faqs.html; Stand: 06.01.2018
    PubMedGoogle Scholar
  • 13 Dayan GH. Quinlisk MP. Parker AA. et al. Recent resurgence of mumps in the United States. New England Journal of Medicine 2008; 358: 1580-1589
    PubMedGoogle Scholar
  • 14 De Serres G. Gay NJ. Farrington CP. Epidemiology of transmissible diseases after elimination. American Journal of Epidemiology 2000; 151: 1039-1048
    PubMedGoogle Scholar
  • 15 Durrheim DN. Crowcroft NS. Strebel PM. Measles – The epidemiology of elimination. Vaccine 2014; 32: 6880-6883
    PubMedGoogle Scholar
  • 16 ECDC. Varicella Vaccination in the European Union. Stockholm; 2015
  • 17 ECDC. Annual Epidemiological Report 2016: Invasive Haemophilus influenzae Disease. Stockholm; 2016
    PubMed
  • 18 ECDC. Surveillance Atlas of Infectious Diseases. Surveillance Atlas of Infectious Diseases. Im Internet: http://atlas.ecdc.europa.eu/public/index.aspx; Stand: 06.01.2018
  • 19 Edmunds WJ. Gay NJ. Kretzschmar M. et al. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: Implications for modelling studies. Epidemiology & Infection 2000; 125: 635-650
    PubMedGoogle Scholar
  • 20 Eurostat. Kinder- und Jugendbevölkerung am 1. Januar nach Geschlecht und Alter. Eurostat. Im Internet: http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=yth_demo_010&lang=de; Stand: 06.01.2018
  • 21 Ewald H. Briel M. Vuichard D. et al. Klinische Wirksamkeit von Pneumokokken-Konjugatimpfstoffen. Dtsch Arztebl International 2016; 113: 139-146
    PubMedGoogle Scholar
  • 22 FDP. BESCHLUSS des 68. Ord. Bundesparteitags der FDP, Berlin, 28. bis 30 April 2017 – Kindeswohl schützen – Recht auf Impfung für alle Kinder 2017; Im Internet: www.fdp.de/sites/default/files/uploads/2017/05/08/2017-04-29-bpt-kindeswohl-schuetzen-recht-auf-impfung-fuer-alle-kinder.pdf; Stand: 06.01.2018
  • 23 Fine PE. Herd immunity: History, theory, practice. Epidemiologic Reviews 1993; 15: 265-302
    PubMedGoogle Scholar
  • 24 Fine P, Eames K, Heymann DL. „Herd Immunity“: A rough guide. Clinical Infectious Diseases 2011; 52: 911-916
    PubMedGoogle Scholar
  • 25 Fox JP. Elveback L. Scott W. et al. Herd immunity: Basic concept and relevance to public health immunization practices. American Journal of Epidemiology 1971; 94: 179-189
    PubMedGoogle Scholar
  • 26 Fox JP. Herd immunity and measles. Review of Infectious Diseases 1983; 5: 463-466
    PubMedGoogle Scholar
  • 27 Gelderblom H. Die Ausrottung der Pocken. Spektrum.de 1996 Im Internet: www.spektrum.de/magazin/die-ausrottung-der-pocken/823065; Stand: 06.01.2018
    PubMed
  • 28 Gesundheitsberichterstattung des Bundes. Sterbefälle Sterbeziffern. Gesundheitsberichterstattung des Bundes. Im Internet: www.gbe-bund.de; Stand: 06.01.2018
  • 29 Glatman-Freedman A. Nichols K. The effect of social determinants on immunization programs. Human Vaccines & Immunotherapeutics 2012; 8: 293-301
    PubMedGoogle Scholar
  • 30 Healy CM. Rench MA. Wootton SH. Castagnini LA. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. The Pediatric Infectious Disease Journal 2015; 34: 22-26 Im Internet: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP: landingpage&an=00006454-201501000-00006; Stand: 06.01.2018
    PubMedGoogle Scholar
  • 31 Hengel H. von Kries R. Impfen. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2009; 52: 1003-1005
    PubMedGoogle Scholar
  • 32 Hirose M. Gilio AE. Ferronato AE. Ragazzi SLB. The impact of varicella vaccination on varicella-related hospitalization rates: Global data review. Revista Paulista de Pediatria (English Edition) 2016; 34: 359-366
    PubMedGoogle Scholar
  • 33 Horn J. Karch A. Damm O. et al. Current and future effects of varicella and herpes zoster vaccination in Germany: Insights from a mathematical model in a country with universal varicella vaccination. Human Vaccines & Immunotherapeutics 2016; 1-11
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Ishiwada N. Addae MM. Tetteh JKA. et al. Vaccine-modified measles in previously immunized children in Accra, Ghana clinical, virological and serological parameters.pdf. Tropical Medicine and International Health 2001; 6: 694-698
    PubMedGoogle Scholar
  • 35 Jónsdóttir. Immunisation of infants in Iceland against Haemophilus influenzae type b. The Lancet 1992; 340: 252-253
    PubMedGoogle Scholar
  • 36 Klinge J. Lugauer S. Korn K. et al. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9–11, 12–14 or 15–17 months of age. Vaccine 2000; 18: 3134-3140
    PubMedGoogle Scholar
  • 37 Ladhani SN. Ramsay ME. Editorial commentary: The story of sisyphus: Why we need a universal pneumococcal vaccine to replace current conjugate vaccines. Clin Infect Dis 2015; 61: 776-778
    PubMedGoogle Scholar
  • 38 Lalwani S. Chatterjee S. Balasubramanian S. et al. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: A phase III, randomised, non-inferiority trial. BMJ open 2015; 5: e007202
    PubMedGoogle Scholar
  • 39 Loo JD. Conklin L. Fleming-Dutra KE. et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. The Pediatric Infectious Disease Journal 2014; 33: S161-S171
    PubMedGoogle Scholar
  • 40 Nardone A. de Ory F. Carton M. et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007 25. Im Internet: DOI: https://doi.org/10.1016/j.vaccine.2007.07.036; Stand: 06.01.2018
    Crossref
  • 41 Nardone A. Tischer A. Andrews N. et al. Comparison of rubella seroepidemiology in 17 countries: Progress towards international disease control targets. Bulletin of the World Health Organization 2008; 86: 118-125
    PubMedGoogle Scholar
  • 42 Olarte L. Barson WJ. Barson RM. et al. Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children. Clinical Infectious Diseases 2015; 61: 767-775
    PubMedGoogle Scholar
  • 43 Orenstein WA. Bernier RH. Dondero TJ. et al. Field evaluation of vaccine efficacy. Bulletin of the World Health Organization 1985; 63: 1055
    PubMedGoogle Scholar
  • 44 Pappenheimer AMJ. Diphtheria. In: Germanier R, Hrsg. Bacterial vaccines. Berne; 1984: 1-36
    PubMed
  • 45 Peltola H. Virtanen M. Systemic Haemophilus influenzae infection in Finland. Clinical Pediatrics 1984; 23: 275-280
    PubMedGoogle Scholar
  • 46 Peltola H. Rød TO. Jónsdóttir K. et al. Life-threatening Haemophilus influenzae infections in Scandinavia: A five-country analysis of the incidence and the main clinical and bacteriologic characteristics. Reviews of Infectious Diseases 1990; 12: 708-715
    PubMedGoogle Scholar
  • 47 Peltola H. Aavitsland P. Hansen KG. et al. Perspective: A five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. The Journal of Infectious Diseases 1999; 179: 223-229
    PubMedGoogle Scholar
  • 48 Puig C. Grau I. Marti S. et al. Clinical and molecular epidemiology of haemophilus influenzae causing invasive disease in adult patients. PLoS ONE 2014; 9: e112711
    PubMedGoogle Scholar
  • 49 Quinlisk MP. Mumps control today. The Journal of Infectious Diseases 2010; 202: 655-656
    PubMedGoogle Scholar
  • 50 Rabe S. Diphtheriefälle in Deutschland 2009–2015. Impf-Info 2017 Im Internet: www.impf-info.de/images/Med/Diphtherie_D_ab_2009.png; Stand: 06.01.2018
    PubMedGoogle Scholar
  • 51 Rabe S. Impfempfehlungen in Europa. Impf-Info 2017 Im Internet: www.impf-info.de/pdfs/Impfempfehlungen_Westeuropa_2017.pdf; Stand: 06.01.2018
    PubMedGoogle Scholar
  • 52 Robert Koch-Institut. RKI – RKI-Ratgeber für Ärzte: Diphtherie. Robert Koch Institut 2009 Im Internet: www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Diphtherie.html; Stand: 06.01.2018
    PubMed
  • 53 Robert Koch-Institut. Diphtherie: Erkrankung durch toxigene Corynebacterium ulcerans nach Katzenkontakt – Fallbericht. Epidemiologisches Bulletin 2011; 2011: 245-248
    Google Scholar
  • 54 Robert Koch-Institut. RKI – RKI-Ratgeber für Ärzte: Mumps. Robert Koch Institut 2013 Im Internet: www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Mumps.html; Stand: 06.01.2018
    PubMed
  • 55 Robert Koch-Institut. Ergebnisse der Modellierung langfristiger epidemiologischer Auswirkungen der Varizellenimpfung in Deutschland. Epidemiologisches Bulletin 2016; 2016: 167-169
    PubMedGoogle Scholar
  • 56 Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2015. Berlin; 2016
    PubMed
  • 57 Robert Koch-Institut. Invasive Meningokokken-Erkrankungen 2012–2015. Epidemiologisches Bulletin 2016; 2016: 471-484
    Google Scholar
  • 58 Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut – 2017/2018. Epidemiologisches Bulletin 2017; 2017: 333-374
    PubMedGoogle Scholar
  • 59 Robert Koch-Institut. Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2015. Epidemiologisches Bulletin 2017; 2017: 137-142
    PubMedGoogle Scholar
  • 60 Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2016. Berlin; 2017
    PubMed
  • 61 Robert Koch-Institut. RKI – Impfungen A–Z: Schutzimpfung gegen Poliomyelitis: Häufig gestellte Fragen und Antworten. Robert Koch Institut 2017. Im Internet: www.rki.de/SharedDocs/FAQ/Impfen/Poliomyelitis/FAQ-Liste_Poliomyelitis_Impfen.html; Stand: 06.01.2018
  • 62 Robert Koch-Institut. RKI – RKI-Ratgeber für Ärzte: Windpocken, Herpes zoster (Gürtelrose). Robert Koch Institut 2017. Im Internet: www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Varizellen.html; Stand: 06.01.2018
  • 63 Robert Koch-Institut. RKI – Ständige Impfkommission. Robert Koch Institut 2017 Im Internet: www.rki.de/DE/Content/Kommissionen/STIKO/stiko_node.html; Stand: 06.01.2018
    PubMed
  • 64 Rosen JB. Rota JS. Hickman CJ. et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clinical Infectious Diseases 2014; 58: 1205-1210
    PubMedGoogle Scholar
  • 65 Saragea A. Maximescu P. Meitert E. Corynebacterium diphtheriae: Microbiological methods used in clinical and epidemiological investigations. In: Bergam T, Norris FR, eds. Methods in Microbiology. New York; 1979: 61-176
  • 66 Schmitz R, Poethko-Muller C, Reiter S, Schlaud M. Impfstatus und Gesundheit von Kindern und Jugendlichen. Deutsches Ärzteblatt International 2011; 108: 99-104
    PubMedGoogle Scholar
  • 67 Smith PG. Concepts of herd protection and immunity. Procedia in Vaccinology 2010; 2: 134-139
    PubMedGoogle Scholar
  • 68 Statens Serum Institut. Theme on temporary change of the childhood vaccination program – Statens Serum Institut. Statens Serum Institut 2016. Im Internet: https://www.ssi.dk/English/News/EPI-NEWS/2016/No%203%20-%202016.aspx; Stand: 06.01.2018
  • 69 Strebel PM. Gacic-Dobo M. Reef S. Cochi SL. Global use of rubella vaccines, 1980–2009. The Journal of Infectious Diseases 2011; 204: S579-S584
    PubMedGoogle Scholar
  • 70 Strebel PM. Measles vaccines. In: Plotkin SA, Orenstein WA, Offit W, eds. Plotkin’s Vaccines. Philadelphia; Elsevier: 2018
    Google Scholar
  • 71 Streng A. Grote V. Carr D. et al. Varicella routine vaccination and the effects on varicella epidemiology–results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006–2011. BMC Infectious Diseases 2013; 13: 303
    PubMedGoogle Scholar
  • 72 Takala AK. Eskola J. Leinonen M. et al. Reduction of oropharyngeal carriage of haemophilus influenzae Type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 1991; 164: 982-986
    PubMedGoogle Scholar
  • 73 Trotter CL. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. American Journal of Epidemiology 2005; 162: 89-100
    PubMedGoogle Scholar
  • 74 Trotter CL. Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Review of Vaccines 2009; 8: 851-861
    PubMedGoogle Scholar
  • 75 Uzicanin A. Zimmerman L. Field effectiveness of live attenuated measles-containing vaccines: A review of published literature. The Journal of Infectious Diseases 2011; 204: S133-S149
    PubMedGoogle Scholar
  • 76 Waight PA. Andrews NJ. Ladhani SN. et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: An observational cohort study. The Lancet Infectious Diseases 2015; 15: 535-543
    PubMedGoogle Scholar
  • 77 Warfel JM. Zimmerman LI. Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proceedings of the National Academy of Sciences 2014; 111: 787-792
    PubMedGoogle Scholar
  • 78 Weinberger DM. Malley R. Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. The Lancet 2011; 378: 1962-1973
    PubMedGoogle Scholar
  • 79 Whittaker R. Economopoulou A. Dias JG. et al. Epidemiology of invasive Haemophilus influenzae Disease, Europe, 2007–2014. Emerging Infectious Diseases 2017; 23: 396-404
    PubMedGoogle Scholar
  • 80 WHO. Pertussis vaccines: WHO position paper. Weekly Epidemiological Record 2010; 85: 385-400
    PubMedGoogle Scholar
  • 81 WHO. Background Paper on Varicella Vaccine – SAGE Working Group on Varicella and Herpes Zoster Vaccines. 2014 Im Internet: www.who.int/immunization/sage/meetings/2014/april/1_SAGE_varicella_background_paper_FINAL.pdf?ua=1; Stand: 06.01.2018
    PubMed
  • 82 WHO. Varicella and herpes zoster vaccines WHO position paper, June 2014. Weekly Epidemiological Record 2014; 89: 265-288
  • 83 WHO. WHO SAGE pertussis working group Background paper SAGE April 2014 Im Internet: www.who.int/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf; Stand: 06.01.2018
    PubMed
  • 84 WHO. Measles vaccines: WHO position paper. Weekly Epidemiological Record 2017; 92: 205-227
    PubMedGoogle Scholar
  • 85 WHO. WHO | WHO recommendations for routine immunization – summary tables. Im Internet: www.who.int/immunization/policy/immunization_tables/en/; Stand: 06.01.2018
    Google Scholar
  • 86 Wiedermann U. Unterschiedliche Impfschemata in Europa: Führen alle Wege nach Rom?. Monatsschrift Kinderheilkunde 2009; 157: 743-750
    Google Scholar
  • 87 Zensusdatenbank Zensus. 2011 Zensusdatenbank – Ergebnisse dynamisch und individuell. Zensus2011. Im Internet: https://ergebnisse.zensus2011.de/#dynTable: statUnit=PERSON;absRel=ANZAHL;ags=00;agsAxis=X;yAxis=ALTER_KURZ:1;table; Stand: 06.01.2018
    PubMed